0001209191-21-061296.txt : 20211021
0001209191-21-061296.hdr.sgml : 20211021
20211021183215
ACCESSION NUMBER: 0001209191-21-061296
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211019
FILED AS OF DATE: 20211021
DATE AS OF CHANGE: 20211021
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jansen Valerie Malyvanh
CENTRAL INDEX KEY: 0001889716
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40523
FILM NUMBER: 211338195
MAIL ADDRESS:
STREET 1: C/O ELEVATION ONCOLOGY, INC.
STREET 2: 888 SEVENTH AVENUE, 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Elevation Oncology, Inc.
CENTRAL INDEX KEY: 0001783032
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 841771427
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 888 SEVENTH AVE
STREET 2: 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
BUSINESS PHONE: 212-651-6380
MAIL ADDRESS:
STREET 1: 888 SEVENTH AVE
STREET 2: 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
FORMER COMPANY:
FORMER CONFORMED NAME: 14ner Oncology, Inc.
DATE OF NAME CHANGE: 20190719
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-10-19
0
0001783032
Elevation Oncology, Inc.
ELEV
0001889716
Jansen Valerie Malyvanh
C/O ELEVATION ONCOLOGY, INC.
888 SEVENTH AVENUE, 12TH FLOOR
NEW YORK
NY
10106
0
1
0
0
Chief Medical Officer
Employee Stock Option (Right to Buy)
7.58
2021-10-19
4
A
0
40000
0.00
A
2031-10-18
Common Stock
40000
40000
D
The stock option vests as to 25% of the total shares on October 19, 2022, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
/s/ Joseph Ferra, Attorney-in-Fact
2021-10-21